MedTrace Logo

Safety and Feasibility of the Transcatheter Tricuspid Valve Repair System (Trialign)

NCT04936802 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2021-06-23

No results posted yet for this study

Summary

The purpose of the study is to demonstrate safety and feasibility of the transcatheter tricuspid valve repair system (Trialign) for the treatment or reduction of moderate to severe functional tricuspid regurgitation.

Conditions

  • Tricuspid Regurgitation

Interventions

DEVICE

Transcatheter tricuspid valve repair system (Trialign)

To assess the Trialign System to treat subjects with moderate to severe tricuspid regurgitation

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Principal Investigators

  • Ling Tao · Xijing Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-25
Primary Completion
2022-06-30
Completion
2023-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04936802 on ClinicalTrials.gov